Your browser doesn't support javascript.
loading
Haplotyping germline and cancer genomes with high-throughput linked-read sequencing.
Zheng, Grace X Y; Lau, Billy T; Schnall-Levin, Michael; Jarosz, Mirna; Bell, John M; Hindson, Christopher M; Kyriazopoulou-Panagiotopoulou, Sofia; Masquelier, Donald A; Merrill, Landon; Terry, Jessica M; Mudivarti, Patrice A; Wyatt, Paul W; Bharadwaj, Rajiv; Makarewicz, Anthony J; Li, Yuan; Belgrader, Phillip; Price, Andrew D; Lowe, Adam J; Marks, Patrick; Vurens, Gerard M; Hardenbol, Paul; Montesclaros, Luz; Luo, Melissa; Greenfield, Lawrence; Wong, Alexander; Birch, David E; Short, Steven W; Bjornson, Keith P; Patel, Pranav; Hopmans, Erik S; Wood, Christina; Kaur, Sukhvinder; Lockwood, Glenn K; Stafford, David; Delaney, Joshua P; Wu, Indira; Ordonez, Heather S; Grimes, Susan M; Greer, Stephanie; Lee, Josephine Y; Belhocine, Kamila; Giorda, Kristina M; Heaton, William H; McDermott, Geoffrey P; Bent, Zachary W; Meschi, Francesca; Kondov, Nikola O; Wilson, Ryan; Bernate, Jorge A; Gauby, Shawn.
Afiliação
  • Zheng GX; 10X Genomics, Pleasanton, California, USA.
  • Lau BT; Stanford Genome Technology Center, Stanford University, Palo Alto, California, USA.
  • Schnall-Levin M; 10X Genomics, Pleasanton, California, USA.
  • Jarosz M; 10X Genomics, Pleasanton, California, USA.
  • Bell JM; Stanford Genome Technology Center, Stanford University, Palo Alto, California, USA.
  • Hindson CM; 10X Genomics, Pleasanton, California, USA.
  • Kyriazopoulou-Panagiotopoulou S; 10X Genomics, Pleasanton, California, USA.
  • Masquelier DA; 10X Genomics, Pleasanton, California, USA.
  • Merrill L; 10X Genomics, Pleasanton, California, USA.
  • Terry JM; 10X Genomics, Pleasanton, California, USA.
  • Mudivarti PA; 10X Genomics, Pleasanton, California, USA.
  • Wyatt PW; 10X Genomics, Pleasanton, California, USA.
  • Bharadwaj R; 10X Genomics, Pleasanton, California, USA.
  • Makarewicz AJ; 10X Genomics, Pleasanton, California, USA.
  • Li Y; 10X Genomics, Pleasanton, California, USA.
  • Belgrader P; 10X Genomics, Pleasanton, California, USA.
  • Price AD; 10X Genomics, Pleasanton, California, USA.
  • Lowe AJ; 10X Genomics, Pleasanton, California, USA.
  • Marks P; 10X Genomics, Pleasanton, California, USA.
  • Vurens GM; 10X Genomics, Pleasanton, California, USA.
  • Hardenbol P; 10X Genomics, Pleasanton, California, USA.
  • Montesclaros L; 10X Genomics, Pleasanton, California, USA.
  • Luo M; 10X Genomics, Pleasanton, California, USA.
  • Greenfield L; 10X Genomics, Pleasanton, California, USA.
  • Wong A; 10X Genomics, Pleasanton, California, USA.
  • Birch DE; 10X Genomics, Pleasanton, California, USA.
  • Short SW; 10X Genomics, Pleasanton, California, USA.
  • Bjornson KP; 10X Genomics, Pleasanton, California, USA.
  • Patel P; 10X Genomics, Pleasanton, California, USA.
  • Hopmans ES; Stanford Genome Technology Center, Stanford University, Palo Alto, California, USA.
  • Wood C; Division of Oncology, Department of Medicine, Stanford University School of Medicine, Stanford, California, USA.
  • Kaur S; 10X Genomics, Pleasanton, California, USA.
  • Lockwood GK; 10X Genomics, Pleasanton, California, USA.
  • Stafford D; 10X Genomics, Pleasanton, California, USA.
  • Delaney JP; 10X Genomics, Pleasanton, California, USA.
  • Wu I; 10X Genomics, Pleasanton, California, USA.
  • Ordonez HS; 10X Genomics, Pleasanton, California, USA.
  • Grimes SM; Stanford Genome Technology Center, Stanford University, Palo Alto, California, USA.
  • Greer S; Division of Oncology, Department of Medicine, Stanford University School of Medicine, Stanford, California, USA.
  • Lee JY; 10X Genomics, Pleasanton, California, USA.
  • Belhocine K; 10X Genomics, Pleasanton, California, USA.
  • Giorda KM; 10X Genomics, Pleasanton, California, USA.
  • Heaton WH; 10X Genomics, Pleasanton, California, USA.
  • McDermott GP; 10X Genomics, Pleasanton, California, USA.
  • Bent ZW; 10X Genomics, Pleasanton, California, USA.
  • Meschi F; 10X Genomics, Pleasanton, California, USA.
  • Kondov NO; 10X Genomics, Pleasanton, California, USA.
  • Wilson R; 10X Genomics, Pleasanton, California, USA.
  • Bernate JA; 10X Genomics, Pleasanton, California, USA.
  • Gauby S; 10X Genomics, Pleasanton, California, USA.
Nat Biotechnol ; 34(3): 303-11, 2016 Mar.
Article em En | MEDLINE | ID: mdl-26829319
Haplotyping of human chromosomes is a prerequisite for cataloguing the full repertoire of genetic variation. We present a microfluidics-based, linked-read sequencing technology that can phase and haplotype germline and cancer genomes using nanograms of input DNA. This high-throughput platform prepares barcoded libraries for short-read sequencing and computationally reconstructs long-range haplotype and structural variant information. We generate haplotype blocks in a nuclear trio that are concordant with expected inheritance patterns and phase a set of structural variants. We also resolve the structure of the EML4-ALK gene fusion in the NCI-H2228 cancer cell line using phased exome sequencing. Finally, we assign genetic aberrations to specific megabase-scale haplotypes generated from whole-genome sequencing of a primary colorectal adenocarcinoma. This approach resolves haplotype information using up to 100 times less genomic DNA than some methods and enables the accurate detection of structural variants.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Haplótipos / Análise de Sequência de DNA / Sequenciamento de Nucleotídeos em Larga Escala / Neoplasias Limite: Humans Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Haplótipos / Análise de Sequência de DNA / Sequenciamento de Nucleotídeos em Larga Escala / Neoplasias Limite: Humans Idioma: En Ano de publicação: 2016 Tipo de documento: Article